175 related articles for article (PubMed ID: 15191645)
1. High-throughput siRNA-based functional target validation.
Xin H; Bernal A; Amato FA; Pinhasov A; Kauffman J; Brenneman DE; Derian CK; Andrade-Gordon P; Plata-Salamán CR; Ilyin SE
J Biomol Screen; 2004 Jun; 9(4):286-93. PubMed ID: 15191645
[TBL] [Abstract][Full Text] [Related]
2. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
3. Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA libraries.
Swearingen EA; Fajardo F; Wang X; Watson JE; Quon KC; Kassner PD
J Biomol Screen; 2010 Jun; 15(5):469-77. PubMed ID: 20371867
[TBL] [Abstract][Full Text] [Related]
4. Process validation and screen reproducibility in high-throughput screening.
Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
[TBL] [Abstract][Full Text] [Related]
5. Streamlining lead discovery by aligning in silico and high-throughput screening.
Davies JW; Glick M; Jenkins JL
Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
[TBL] [Abstract][Full Text] [Related]
6. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Median absolute deviation to improve hit selection for genome-scale RNAi screens.
Chung N; Zhang XD; Kreamer A; Locco L; Kuan PF; Bartz S; Linsley PS; Ferrer M; Strulovici B
J Biomol Screen; 2008 Feb; 13(2):149-58. PubMed ID: 18216396
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening: update on practices and success.
Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
[TBL] [Abstract][Full Text] [Related]
10. High-content siRNA screening.
Krausz E
Mol Biosyst; 2007 Apr; 3(4):232-40. PubMed ID: 17372651
[TBL] [Abstract][Full Text] [Related]
11. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells.
Kaykas A; Moon RT
BMC Cell Biol; 2004 Apr; 5():16. PubMed ID: 15119963
[TBL] [Abstract][Full Text] [Related]
12. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.
Perrimon N; Friedman A; Mathey-Prevot B; Eggert US
Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970
[TBL] [Abstract][Full Text] [Related]
13. High-throughput RNA interference strategies for target discovery and validation by using synthetic short interfering RNAs: functional genomics investigations of biological pathways.
Sachse C; Krausz E; Krönke A; Hannus M; Walsh A; Grabner A; Ovcharenko D; Dorris D; Trudel C; Sönnichsen B; Echeverri CJ
Methods Enzymol; 2005; 392():242-77. PubMed ID: 15644186
[TBL] [Abstract][Full Text] [Related]
14. Smart screening: approaches to efficient HTS.
Engels MF; Venkatarangan P
Curr Opin Drug Discov Devel; 2001 May; 4(3):275-83. PubMed ID: 11560058
[TBL] [Abstract][Full Text] [Related]
15. Integrated expressional analysis: application to the drug discovery process.
Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
[TBL] [Abstract][Full Text] [Related]
16. Designing, optimizing, and implementing high-throughput siRNA genomic screening with glioma cells for the discovery of survival genes and novel drug targets.
Thaker NG; McDonald PR; Zhang F; Kitchens CA; Shun TY; Pollack IF; Lazo JS
J Neurosci Methods; 2010 Jan; 185(2):204-12. PubMed ID: 19782703
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
18. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
20. An efficient and fully automated high-throughput transfection method for genome-scale siRNA screens.
Chung N; Locco L; Huff KW; Bartz S; Linsley PS; Ferrer M; Strulovici B
J Biomol Screen; 2008 Feb; 13(2):142-8. PubMed ID: 18216392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
